Literature DB >> 32205096

More accurate LDL-C calculation: Externally validated, guideline endorsed.

Adam J Brownstein1, Seth S Martin2.   

Abstract

Low density lipoprotein-cholesterol (LDL-C) serves as the primary target of therapy for preventing atherosclerotic cardiovascular disease (ASCVD). Recently released European and American guidelines on lipid management recommend attaining very low LDL-C levels (<1.8 mmol/L or even lower) in high and very-high risk patients. Therefore, utilizing an accurate means for determining LDL-C, especially at such low values, is of paramount importance to inform the best clinical decisions and use of effective therapies. This review compares the different methods of determining LDL-C, including the various forms of direct measurement and most commonly used calculations. This review discusses the evidence behind these methods in different populations of patients and in the fasting versus non-fasting state. The Martin/Hopkins method is the preferred method for determining LDL-C as it is the most accurate and widely applicable method. It is especially useful in patients with low LDL-C levels < 1.8 mmol/L (<70 mg/dL) and high triglyceride levels between 1.7 and 4.5 mmol/L (150-399 mg/dL), and is reliable in the non-fasting state.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Friedewald equation; Low density lipoprotein-cholesterol (LDL-C); Martin-Hopkins equation; Non-fasting lipid panel; PCSK9 inhibitors; Statins

Mesh:

Substances:

Year:  2020        PMID: 32205096     DOI: 10.1016/j.cca.2020.03.030

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  A Modern Approach to Dyslipidemia.

Authors:  Amanda J Berberich; Robert A Hegele
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

2.  Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations.

Authors:  Gözde Ertürk Zararsız; Serkan Bolat; Ahu Cephe; Necla Kochan; Serra İlayda Yerlitaş; Halef Okan Doğan; Gökmen Zararsız
Journal:  PLoS One       Date:  2022-05-13       Impact factor: 3.752

3.  Clinical Validation of Eleven Formulas for Calculating LDL-C in Iran.

Authors:  Fereshteh Atabi; Reza Mohammadi
Journal:  Iran J Pathol       Date:  2020-07-18

4.  Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels.

Authors:  Aparna Sajja; Jihwan Park; Vasanth Sathiyakumar; Bibin Varghese; Vincent A Pallazola; Francoise A Marvel; Krishnaji Kulkarni; Alagarraju Muthukumar; Parag H Joshi; Eugenia Gianos; Benjamin Hirsh; Guy Mintz; Anne Goldberg; Pamela B Morris; Garima Sharma; Roger S Blumenthal; Erin D Michos; Wendy S Post; Mohamed B Elshazly; Steven R Jones; Seth S Martin
Journal:  JAMA Netw Open       Date:  2021-10-01

5.  Directly Measured vs. Calculated Low-Density Lipoprotein Cholesterol Does Not Identify Additional Individuals With Coronary Artery Disease and Diabetes at Higher Risk of Adverse Events: Insight From a Large Percutaneous Coronary Intervention Cohort in Asia.

Authors:  Boqun Shi; Hao-Yu Wang; Jinpeng Liu; Zhongxing Cai; Chenxi Song; Lei Jia; Dong Yin; Hongjian Wang; Ke-Fei Dou; Weihua Song
Journal:  Front Cardiovasc Med       Date:  2022-07-07

6.  Cordova Formula for Low-Density Lipoprotein- Cholesterol Estimation: Not Only the Simplest of All But Also Superior to Other Formulae at a Higher Range of Triglyceride.

Authors:  Sojit Tomo; Shrimanjunath Sankanagoudar; Praveen Sharma
Journal:  Anatol J Cardiol       Date:  2022-07       Impact factor: 1.475

7.  Remnant cholesterol is associated with cardiovascular mortality.

Authors:  Kerui Zhang; Xiangyun Qi; Fuyu Zhu; Quanbin Dong; Zhongshan Gou; Fang Wang; Li Xiao; Menghuan Li; Lianmin Chen; Yifeng Wang; Haifeng Zhang; Yanhui Sheng; Xiangqing Kong
Journal:  Front Cardiovasc Med       Date:  2022-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.